Table 1.
Clinical and biochemical characteristics in patients with STEMI.
| n = 68 | |||
|
| |||
| Female sex, n (%) | 12 (17.6) | ||
| Age, years | 61.51 ± 14.72 | ||
| DM, n (%) | 12 (17.6) | ||
| HT, n (%) | 29 (42.6) | ||
| DL, n (%) | 8 (11.8) | ||
| Smoking, n (%) | 51 (75) | ||
| Family history of CAD, n (%) | 9 (13.4) | ||
| Admission time (hours) | 4.61 ± 2.96 | ||
| Admission SBP (mmHg) | 114.93 ± 22.58 | ||
| Anterior wall MI, n (%) | 25 (36.8) | ||
| Inferior wall MI, n (%) | 33 (48.5) | ||
| Posterolateral wall MI, n (%) | 10 (14.7) | ||
| Primer PCI, n (%) | 40 (58.8) | ||
| Fibrinolytic administration, n (%) | 30 (44.1) | ||
| NGAL (ng/ml) | 190.08 (9.00–694.00) | ||
| Troponin I (ng/ml) | 1.51 (0.10–25.00) | ||
| CKMB (ng/ml) | 14.99 (1.63–380.00) | ||
| CRP (mg/dl) | 0.53 (0.05–9.59) | ||
| Creatinine (mg/dl) | 0.88 ± 0.19 | ||
| GFR (ml/min) | 101.47 ± 23.29 | ||
| LDL (mg/dl) | 124.35 ± 34.70 | ||
| HDL (mg/dl) | 36.65 ± 9.04 | ||
| Haemoglobin (mg/dl) | 14.83 ± 2.27 | ||
| Leukocytes (K/uL) | 12.27 ± 0.45 | ||
| Platelets (K/uL) | 240 (72–485) | ||
| Neutrophils (K/uL) | 8.99 ± 4.07 | ||
| Lymphocytes (K/uL) | 2.21 ± 1.39 | ||